| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/22/2007 | WO2007021262A1 USE OF ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION |
| 02/22/2007 | WO2007020935A1 Therapeutic agent for pain comprising p2y12 receptor and/or p2y14 receptor blocker |
| 02/22/2007 | WO2007020509A1 Combination of methylol transfer agents with tumour-inhibiting proteins or peptides and the use thereof for the treatment of cancer or tumor growth |
| 02/22/2007 | WO2007020478A1 Virucidal solutions |
| 02/22/2007 | WO2006123279A3 Natural drugs containing calcium and phosphate and apparatus for iontophoretic treatment of osteoporosis |
| 02/22/2007 | WO2006118916A3 Methods and compositions for polytopic vaccination |
| 02/22/2007 | WO2006112744A3 Drug composition with analgesic, anti-inflammatory and decongestive activity |
| 02/22/2007 | WO2006019841A3 Treatment of viral infections with egr 1 activators |
| 02/22/2007 | WO2005094376A3 Synergistic methods and compositions for treating cancer |
| 02/22/2007 | WO2005062957A3 Compositions and methods for combined therapy of disease |
| 02/22/2007 | WO2005011616A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease |
| 02/22/2007 | WO2004098491A3 METHOD OF PREVENTING INFECTIONS FROM BIOTERRORISM AGENTS WITH IMMUNOSTIMULATORY CpG OLIGONUCLEOTIDES |
| 02/22/2007 | US20070044166 P2Y4 Receptor transgenic and knockout non-human mammals |
| 02/22/2007 | US20070043114 Nerve regeneration promoters |
| 02/22/2007 | US20070043110 Nontoxic potentiation sensitization of ovarian cancer therapy by supplementary treatment with vitamins |
| 02/22/2007 | US20070043070 Weak base salts |
| 02/22/2007 | US20070043006 Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis |
| 02/22/2007 | US20070043005 Treatment of hyperproliferative diseases using high doses of active vitamin d |
| 02/22/2007 | US20070043001 Cancer; 1-(1-{4-[5-(5-amino-1,3,4-thiadiazol-2-yl)-3-phenylpyridin-2-yl]benzyl}piperidin-4-yl) -1H-pyrazolo[3,4-d]pyrimidin-4-amine; serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, enhanced pharmacokinetic properties |
| 02/22/2007 | US20070042990 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/22/2007 | US20070042973 Treatment of pain and fever |
| 02/22/2007 | US20070042965 Crystallized structure of type IV collagen NC1 domain hexamer |
| 02/22/2007 | US20070042947 Agents for preventing and/or treating uppper digestive tract disorders |
| 02/22/2007 | US20070042945 Nouvelles compositions et methods de traitement du psoriasis |
| 02/22/2007 | US20070042938 Use of dpiv and apn inhibitors for the treatment of dermatalogical diseases involving the hyperproliferation and modified differentiation conditions of fibroblasts |
| 02/22/2007 | US20070042492 Amino acid sequences for transferring substances of interest from outside medium to inside of cells, specifically cell nuclei; useful for enhancing delivery of drugs into cytoplasm and/or the cell nucleus from the host organism being treated |
| 02/22/2007 | US20070042057 Compositions for the treatment and prevention of diabetes mellitus |
| 02/22/2007 | US20070042032 Self forming, thermodynamically stable liposomes and their applications |
| 02/22/2007 | US20070042019 Method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 02/22/2007 | US20070041964 WISP polypeptides and nucleic acids encoding same |
| 02/22/2007 | US20070041956 Vaccine immunotherapy for immune suppressed patients |
| 02/22/2007 | US20070041939 Modified cytokines for use in cancer therapy |
| 02/22/2007 | US20070041908 Injectable composite for the magnetocytolysis of bone metastatic cells |
| 02/22/2007 | US20070041866 Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant |
| 02/22/2007 | DE102005033942A1 Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für Antiemetikum oder Antimigränemittel Non-ausspuckbarer, oral, fast-disintegrating film for anti-emetic or anti-migraine agents |
| 02/22/2007 | DE10101522B4 Neue pharmazeutische Verwendung einer Kombination aus Ascorbat und mindestens einem Fibrinolysehemmer New pharmaceutical use a combination of ascorbate and at least one Fibrinolysehemmer |
| 02/22/2007 | CA2619219A1 Use of .beta.-1,3 (4)-endoglucanohydrolase, .beta.-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function |
| 02/21/2007 | EP1754788A2 Prostate-specific membrane antigen and uses thereof |
| 02/21/2007 | EP1754719A2 Anti-osteopontin antibody and use thereof |
| 02/21/2007 | EP1754492A1 Novel drug discovery target and medicine acting on the same |
| 02/21/2007 | EP1754491A1 Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist |
| 02/21/2007 | EP1754480A2 Compositions comprising phospholipase c inhibitors and methods for enhancing paracellular permeability across epithelial and endothelial barriers |
| 02/21/2007 | EP1754472A2 Compositions for treatment of disorders associated with chlamydia |
| 02/21/2007 | EP1753860A2 Intervertebral disc repair, methods and devices therefor |
| 02/21/2007 | EP1753460A2 Combination of atypical antipsychotics and 5-ht1b receptor antagonists |
| 02/21/2007 | EP1753459A2 Composition and method for improving pancreatic islet cell survival |
| 02/21/2007 | EP1753458A2 Modulation of immunoglobulin production and atopic disorders |
| 02/21/2007 | EP1753413A2 Novel medical uses of compounds showing cb sb 1/sb -antagonistic activity and combination treatment involving said compounds |
| 02/21/2007 | EP1753397A2 Galantamine salts, method of producing it and nasal composition thereof |
| 02/21/2007 | EP1578369A4 Screening strategy for anticancer drugs |
| 02/21/2007 | EP1523325A4 Methods and compositions for treating polycystic ovary syndrome |
| 02/21/2007 | EP1458725B1 A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | EP1339428B1 Inhalation of nitric oxide |
| 02/21/2007 | EP1328546B1 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/21/2007 | EP1294422A4 Methods and systems for enhancing fluid flow through an obstructed vascular site |
| 02/21/2007 | EP1232177B1 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 02/21/2007 | EP1140071B1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 02/21/2007 | EP1135503B1 Drug targets in candida albicans |
| 02/21/2007 | EP1086225B1 Human tumour-derived polypeptide hormone phosphatonin |
| 02/21/2007 | EP1057483B1 Composition comprising theanine |
| 02/21/2007 | EP1003787B1 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 02/21/2007 | EP0954334B1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
| 02/21/2007 | CN1918171A Chemokine ccr5 receptor modulators |
| 02/21/2007 | CN1918128A Fused ring 4-oxopyrimidine derivative |
| 02/21/2007 | CN1918114A Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders |
| 02/21/2007 | CN1917903A New combinations of an anti emetic agent and an enkephalinase inhibitor |
| 02/21/2007 | CN1917890A Composition and method for use in cartilage affecting conditions |
| 02/21/2007 | CN1917887A The use of o-atp for the treatment of diseases involving angiogenesis |
| 02/21/2007 | CN1917882A Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists |
| 02/21/2007 | CN1917877A Combination of a farnesyl tranferase inhibitor with an antihormonal agent for the treatment of breast cancer |
| 02/21/2007 | CN1917876A Methods and compositions |
| 02/21/2007 | CN1917865A Combination of organic compounds |
| 02/21/2007 | CN1917864A Pharmaceutical composition of a sodium channel blocker and a selective serotonin uptake inhibitor |
| 02/21/2007 | CN1916009A Process for preparing amine platinum complexes |
| 02/21/2007 | CN1915971A Prostaglandin-like compound and its uses for treatment of external secretion disorders |
| 02/21/2007 | CN1915429A Combinations of the peroxisome proliferator-activated receptor (ppar) activator fenofibrate with sterol absorption inhibitor ezetimibe for vascular indications |
| 02/21/2007 | CN1915428A Synergistic therapeutic compositions and methods |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/20/2007 | US7179912 Materials and methods to potentiate cancer treatment |
| 02/20/2007 | US7179891 A proteinaceous part having TNF activity and a high molecular polyethylene part bound artificially to the N-terminus of the proteinaceous part, with higher stability; antitumor agents |
| 02/20/2007 | US7179883 Biocompatibility; biopolymers such as poly-4-hydroxybutyrate, poly-4-hydroxybutyrate-co-3-hydroxybutyrate, poly-4-hydroxybutyrate-co-2-hydroxybutyrate, and copolymers and blends; controlled degradation rate; grafting |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179811 Such as N-[1-(2-amino-3-methylbutyl)-4-piperidinyl]-3-[(2-methoxyethoxy)(6-methyl-2-pyridinyl)methyl]-7-methyl-3H-imidazo[4,5-b]pyridin-2-amine; infant infections |
| 02/20/2007 | US7179803 Method of modulating ion channel functional activity |
| 02/20/2007 | US7179792 Combination product of a 1,4-benzothiepine 1,1-dioxide compound with at least one other active ingredient and the use of the product |
| 02/20/2007 | US7179789 Peptide copper complex with corticosteroid, metronidazole, sulfacetamide, sulfur, and/or azelaic acid for topical administration; cosmetics |
| 02/20/2007 | US7179627 Cyclooxygenase variants and methods of use |
| 02/20/2007 | US7179610 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 02/20/2007 | US7179493 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 02/20/2007 | US7179463 Treatment of alzheimer's disease |
| 02/20/2007 | US7179462 α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof |
| 02/20/2007 | US7178480 Method of reducing risk of infection of a bovine teat after cessation of milking |
| 02/20/2007 | CA2407429C Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof |
| 02/20/2007 | CA2365078C Dietary compositions and methods |
| 02/20/2007 | CA2344574C Thyroid receptor ligands |
| 02/20/2007 | CA2289979C Methods of modulating immune coagulation |
| 02/20/2007 | CA2283929C Method for treating headache pain with topical local anesthetic compositions |
| 02/20/2007 | CA2218872C Preparation and use of sulfated oligosaccharides |